Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Casirivimab
Screening
Emergency use authorization Experimental Antiviral Jan/23/2023
Imdevimab
Screening
Emergency use authorization Experimental Antiviral Jan/23/2023
Remdesivir
Screening
Approved by FDA Experimental Antiviral Jan/18/2023
Sotrovimab
Screening
Emergency use authorization Experimental Antiviral Jul/14/2022
Bamlanivimab
Screening
Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
Etesevimab
Screening
Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
Cilgavimab
Screening
Emergency use authorization Experimental Antiviral Jun/18/2022
Tixagevimab
Screening
Emergency use authorization Experimental Antiviral Jun/18/2022
mAb 222
Screening
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
mAb Beta-55
Screening
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
mAb Beta-29
Screening
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
mAb Beta-54
Screening
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
mAb Beta-53
Screening
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
mAb Beta-47
Screening
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
mAb Beta-40
Screening
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
mAb Beta-56
Screening
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
Emtricitabine
Screening
Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/20/2021
Tenofovir
Screening
Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/20/2021
mAb Beta-22
Screening
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/27/2021
mAb Beta-27
Screening
Potential treatment - pre-clinical evidence Experimental Antiviral Nov/27/2021